Location History:
- Cambridge, MA (US) (2009)
- Linthicum, MD (US) (2009 - 2012)
Company Filing History:
Years Active: 2009-2012
Title: Innovations and Contributions of Inventor Blake Hamann
Introduction
Blake Hamann is a notable inventor based in Linthicum, MD (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of four patents to his name, he has made strides in developing innovative compounds that target critical biological pathways.
Latest Patents
Among his latest patents, Hamann has developed "Substituted pyridines that are JNK inhibitors." This invention discloses compounds of the formula (I) wherein X is N or CH, and Y is N or CR. The methods outlined in this patent focus on treating JNK and ERK mediated diseases using these compounds. Another significant patent is for "Imidazopyrazines as cyclin dependent kinase inhibitors." This invention presents a novel class of imidazo[1,2-a]pyrazine compounds that serve as inhibitors of cyclin dependent kinases. It includes methods for preparing these compounds, pharmaceutical compositions containing them, and methods for treating diseases associated with CDKs.
Career Highlights
Throughout his career, Blake Hamann has worked with prominent companies such as Schering Corporation and Merck Sharp & Dohme Corporation. His experience in these organizations has contributed to his expertise in pharmaceutical innovation and development.
Collaborations
Hamann has collaborated with notable colleagues, including M Arshad Siddiqui and David Benjamin Belanger. These partnerships have likely enhanced his research and development efforts in the pharmaceutical sector.
Conclusion
Blake Hamann's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His patents reflect a commitment to advancing medical treatments and improving patient outcomes.